You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 1, January 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Endocrine Diseases
 •Thyroid/ Parathyroid Diseases
 •Endocrine Surgery
 •Surgical Oncology
 •Otolaryngology/ Head & Neck Surgery
 •Alert me on articles by topic

Skip Metastases in Thyroid Cancer Leaping the Central Lymph Node Compartment

Andreas Machens, MD; Hans-Jürgen Holzhausen, MD; Henning Dralle, MD

Arch Surg. 2004;139:43-45.

Hypothesis  Discontinuous nodal metastasis, or skip metastasis, in thyroid cancer may display clinicopathologic features different from those seen in continuous nodal metastasis and thus may have a different prognosis.

Design  Retrospective analysis.

Setting  Tertiary referral center at a university hospital.

Patients  Two hundred fifteen consecutive patients who underwent systematic central lymph node dissection for papillary, follicular, or medullary thyroid cancer and who on histopathologic analysis exhibited nodal metastases in at least 1 lateral or mediastinal lymph node compartment.

Main Outcome Measures  Various clinicopathologic variables that were stratified for tumor entity and type of nodal metastasis (discontinuous vs continuous).

Results  Skip metastases (negative central and positive lateral or mediastinal compartments) were found in 13 (19.7%) of 66 papillary, 0 of 8 follicular, and 30 (21.3%) of 141 medullary thyroid cancers. After adjustment for multiple testing, skip metastasis was only associated with significantly fewer positive lymph nodes: 3.7 vs 12.9 nodes (r = -0.43, P<.001) in papillary thyroid cancer and 6.0 vs 17.1 nodes (r = -0.40, P<.001) in medullary thyroid cancer. No other significant correlation was identified with any other clinicopathologic variable.

Conclusions  Skip metastasis is an epiphenomenon of low-intensity nodal metastasis in thyroid cancer and entails a moderate risk of local recurrence. Consequently, clearing the central lymph node compartment should be considered when lateral or mediastinal lymph node compartments are involved.


From the Departments of General, Visceral, and Vascular Surgery (Drs Machens and Dralle) and Pathology (Dr Holzhausen), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lateral Cervical Lymph Node Metastases from Papillary Thyroid Carcinoma: Pattern of Nodal Metastases and Optimal Strategy for Neck Dissection
Roh et al.
Ann. Surg. Oncol. 2008;15:1177-1182.
ABSTRACT | FULL TEXT  

Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis
Leboulleux et al.
J. Clin. Endocrinol. Metab. 2005;90:5723-5729.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.